GLP-1 Research Compounds
Molecular Weight: 4731.33 Da | Receptors: GLP-1 · GIP · GCGR | Form: Lyophilized | Purity: 99%+ HPLC
Mechanism of action
Why Researchers Choose GLP-1R
01
Triple-Receptor Agonism (GGG) Simultaneously engages the GLP-1, GIP, and glucagon receptors in a single molecule — a unique tool for multi-pathway
metabolic signaling research.
02
Glucagon-Receptor Energy Metabolism GCGR activation is studied for its role in glycogen and lipid mobilization and increased basal energy expenditure in metabolic
models.
03
Appetite & Satiety Pathway Research GIP and GLP-1 receptor engagement is researched for central and peripheral appetite-signaling and food-intake regulation in
preclinical models.
04
Gastric-Emptying & Glucose-Homeostasis Studie Documented in research to slow gastric emptying and modulate glucose regulation — key parameters in incretin pharmacology
05
Extended Research Half-Life Albumin-binding modifications give a prolonged half-life suited to weekly preclinical study protocols.
06
99%+ HPLC-Verified Purity Independently verified by third-party laboratories via HPLC and LC-MS; batch-specific COA and SDS available pre-purchase.
GLP-1R (Retatrutide) is a tri-agonist built on a modified GIP backbone with albumin-binding modifications that extend its half-life for
weekly research protocols. It engages three key metabolic receptors:
Structure & purity specifications
- GIPR (Gastric Inhibitory Polypeptide Receptor):
- Relays fullness / satiety signaling from the gut, supporting food-intake regulation studies.